Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
J Pharmacol Exp Ther. 1997 Feb;280(2):710-20.
J Pharmacol Exp Ther. 1997.
PMID: 9023283
Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease.
Fink DM, Bores GM, Effland RC, Huger FP, Kurys BE, Rush DK, Selk DE.
Fink DM, et al. Among authors: selk de.
J Med Chem. 1995 Sep 1;38(18):3645-51. doi: 10.1021/jm00018a025.
J Med Chem. 1995.
PMID: 7658452
Item in Clipboard
Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW Jr, Davis L, Vargas HM.
Bores GM, et al. Among authors: selk de.
J Pharmacol Exp Ther. 1996 May;277(2):728-38.
J Pharmacol Exp Ther. 1996.
PMID: 8627552
Item in Clipboard
On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia.
Black MD, Selk DE, Hitchcock JM, Wettstein JG, Sorensen SM.
Black MD, et al. Among authors: selk de.
Neuropharmacology. 1999 Sep;38(9):1299-306. doi: 10.1016/s0028-3908(99)00041-6.
Neuropharmacology. 1999.
PMID: 10471083
Item in Clipboard
Cite
Cite